Private Equity

With its fourth acquisition under ZCG ownership, Unimed is consolidating the fragmented maritime health market, leveraging tech to create a dominant platform.

Genmab's $8 billion acquisition of Merus isn't just a deal; it's a bold strategy to own its destiny and dominate the future of oncology therapeutics.

An independent study shows Mesoblast’s cell therapy has superior remission rates over a market leader, hinting at a new standard of care and a big win for investors.

The private capital market leader's latest user-voted award reveals a major trend: authentic customer feedback is the new currency in high-stakes investing.

With a $2.5B boost from Blue Owl, Finance of America aims to move beyond reverse mortgages and reshape how millions of retirees access their home equity.

AMC's key governance reforms failed despite 90% voter support, stymied by low turnout. Meanwhile, a major share increase passed. What does this mean?

BrightView Holdings declared its eighth straight cash dividend, a move signaling financial discipline even as it navigates revenue challenges and stock volatility.

Tenaya Therapeutics seeks fresh capital to advance its heart disease pipeline, but the offering's structure raises dilution questions for investors.

Excelerate Energy signals deep confidence with a new $75M share buyback, balancing shareholder rewards with an ambitious global expansion in the LNG market.

Argan's repeated dividend hikes and record backlog reflect deep confidence, positioning it to capitalize on surging demand for critical energy infrastructure.

A top advisor's move to independence reveals a major shift in how ultra-high-net-worth families are securing multi-generational wealth and resilience.

A shocking 9,000% rise in senior overdose deaths sparks a new video initiative. But is education enough to combat a crisis hidden in plain sight?

Austria’s famed Flying Bulls bring two historic aircraft to the US for one show only. A deep dive into the business of heritage and a transatlantic feat.

A rejected $307M Danone offer and claims of poor governance fuel a bitter proxy fight at Lifeway Foods, pitting CEO against her largest shareholder—her brother.

An Atlanta initiative is scaling a proven model to close the 'word gap.' It's not just about equity; it's a long-term investment in our future economy.

With $150M from Crayhill Capital, Rostrum Pacific isn't just buying music history—it's building an integrated ecosystem to redefine its future.

With a new CEO, Menagerie Cellars is doubling down on its blend of luxury wine and conservation. Can this purpose-driven model scale in a tough market?

As Dallas-Fort Worth's skyline expands, American Elevator Company's entry signals intensified competition in the crucial building services sector.

More than just a path, Jacksonville's Emerald Trail is a national model for driving economic growth, social equity, and urban revitalization.

A hedge fund's disclosure reveals a puzzling short position and a fresh stock purchase in American Axle, hinting at a high-stakes arbitrage play.